When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
Engineers have developed 3D-printable miniature "fish" that may be capable of propelling themselves through blood vessels and delivering drugs to specific cells.
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with a featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing updates…
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related…
Edmond J. LaVoie, PhD, Professor and Chair of the Department of Medicinal Chemistry at Rutgers University, discusses the potential of a new antibiotic to combat the increasing problems…
MIT demonstrates the "origami robot" - measuring just one-centimeter in length and controlled via magnetic-field manipulation, this tiny bot will dissolve in liquid when its useful life has…
Rebecca Kaltman, MD, feeling frustrated with the limitations and shortcomings of a traditional medical practice, decided to found Breast Cancer Consultants – an online, direct-to-patient, breast cancer consultation…
